Gowri Rangaswamy Gunassekaran

Author

Kyungpook National University

Also Known As

Gowri Rangaswamy Gunassekaran

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kyungpook National University Pohang University of Science and Technology Institute for Basic Science Korea Advanced Institute of Science and Technology Korea University

About

Gowri Rangaswamy Gunassekaran is an author at Kyungpook National University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	570
2	Cell Biology	5	5	570
3	Immunology	5	5	570
4	Immunotherapy	4	4	135
5	Autoimmunity	1	1	16

Gowri Rangaswamy Gunassekaran

Publications

854

Citations

H-Index

Page 1

	Year	Citations
M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages Gowri Rangaswamy Gunassekaran, Sri Murugan Poongkavithai Vadevoo, Moon‐Chang Baek, Biomaterials M1-like MacrophagesImmunologyExtracellular MicrovesiclesM1 MacrophageMedicine	2021	435
The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages Sri Murugan Poongkavithai Vadevoo, Gowri Rangaswamy Gunassekaran, ChaeEun Lee, Proceedings of the National Academy of Sciences	2021	116
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression Smriti Gurung, Fatima Khan, Gowri Rangaswamy Gunassekaran, Biomaterials Cancer ImmunosurveillanceSignal TransductionInhibit Tumor ProgressionPeptide LibraryDisplay-identified Pd-l1-binding Peptides	2020	69
A Peptide Probe Enables Photoacoustic-Guided Imaging and Drug Delivery to Lung Tumors in <i>K-rasLA2</i> Mutant Mice Hyun-Kyung Jung, Sungjo Park, Gowri Rangaswamy Gunassekaran, Cancer Research	2019	41
Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth Guruprasath Padmanaban, Jihoon Kim, Gowri Rangaswamy Gunassekaran, Biomaterials Bcl-xl SirnaInterleukin-4 Receptor-targeted DeliveryMedicineTumor GrowthImmunology	2017	36
IL4 Receptor–Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity Sri Murugan Poongkavithai Vadevoo, Jung‐Eun Kim, Gowri Rangaswamy Gunassekaran, Molecular Cancer Therapeutics	2017	36
Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p Sri Murugan Poongkavithai Vadevoo, Gowri Rangaswamy Gunassekaran, Jae Do Yoo, Frontiers in Immunology	2022	27
IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis Sri Murugan Poongkavithai Vadevoo, Yeoul Kang, Gowri Rangaswamy Gunassekaran, Theranostics	2024	27
Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice Fatima Khan, Smriti Gurung, Gowri Rangaswamy Gunassekaran, Theranostics	2020	25
Non-genetic engineering of cytotoxic T cells to target IL-4 receptor enhances tumor homing and therapeutic efficacy against melanoma Gowri Rangaswamy Gunassekaran, Chae Moon Hong, Sri Murugan Poongkavithai Vadevoo, Biomaterials Cancer ImmunosurveillanceCytotoxic T CellsT-regulatory CellImmunologyTumor Immunity	2018	16

Page 1